Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors (Q33357008)
Jump to navigation
Jump to search
scientific article published on September 15, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors |
scientific article published on September 15, 2003 |
Statements
1 reference
Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors (English)
1 reference
Mario Sznol
1 reference
John Murren
1 reference
Manuel Modiano
1 reference
Caroline Clairmont
1 reference
Paula Lambert
1 reference
Niramol Savaraj
1 reference
Terry Doyle
1 reference
1 September 2003
1 reference
15 September 2003
1 reference